IGNIS THERAPEUTICS
Ignis Therapeutics is a innovative therapies in the field of central nervous system.
IGNIS THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
180 M USD
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Investors List
WTT Investment
WTT Investment investment in Series A - Ignis Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series A - Ignis Therapeutics
Ruentex Group
Ruentex Group investment in Series A - Ignis Therapeutics
KB Investment
KB Investment investment in Series A - Ignis Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Ignis Therapeutics
Goldman Sachs
Goldman Sachs investment in Series A - Ignis Therapeutics
Mubadala Petroleum
Mubadala Petroleum investment in Series A - Ignis Therapeutics